APA (7th ed.) Citation

Azar, I., Alkassis, S., Fukui, J., Alsawah, F., Fedak, K., Al Hallak, M. N., . . . Nagasaka, M. (2021). Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy, 12, 103-114. https://doi.org/10.2147/lctt.s307324

Chicago Style (17th ed.) Citation

Azar, Ibrahim, Samer Alkassis, Jami Fukui, Fares Alsawah, Kalub Fedak, Mohammed Najeeb Al Hallak, Ammar Sukari, and Misako Nagasaka. "Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer." Lung Cancer: Targets and Therapy 12 (2021): 103-114. https://doi.org/10.2147/lctt.s307324.

MLA (9th ed.) Citation

Azar, Ibrahim, et al. "Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer." Lung Cancer: Targets and Therapy, vol. 12, 2021, pp. 103-114, https://doi.org/10.2147/lctt.s307324.